132 related articles for article (PubMed ID: 1077765)
1. Inhibition of the pressor and aldosterone-releasing effects of angiotensin II.
Bumpus FM; Khosla MC
Clin Sci Mol Med Suppl; 1975 Jun; 2():15s-18s. PubMed ID: 1077765
[TBL] [Abstract][Full Text] [Related]
2. Actions of angiotensin II antagonists upon aldosterone production by isolated adrenal glomerulosa cells.
Saltman S; Fredlund P; Catt KJ
Endocrinology; 1976 Apr; 98(4):894-903. PubMed ID: 1278097
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of Asp-angiotensin II and Sar-angiotensin II on vascular and adrenal receptors in the dog.
Bravo EL; Khosla MC; Bumpus FM
Clin Sci Mol Med; 1976 Jul; 51(1):41-5. PubMed ID: 939065
[TBL] [Abstract][Full Text] [Related]
4. Influence of the adrenal gland on the pressor effect and antagonistic potency of angiotensin II analogs.
Muñoz-Ramírez H; Khosla MC; Bumpus FM; Khairallah PA
Eur J Pharmacol; 1975 Mar; 31(1):122-35. PubMed ID: 236194
[TBL] [Abstract][Full Text] [Related]
5. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin III binding in the rat adrenal glomerulosa.
Douglas JG; Khosla MC; Bumpus FM
Endocrinology; 1985 Apr; 116(4):1598-602. PubMed ID: 3971929
[TBL] [Abstract][Full Text] [Related]
7. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Chang RS; Lotti VJ
Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
[TBL] [Abstract][Full Text] [Related]
8. Comparative receptor-binding properties of heptapeptide and octapeptide antagonists of angiotensin II in rat adrenal glomerulosa and uterine smooth muscle.
Douglas JG; Michailov M; Khosla MC; Bumpus FM
Endocrinology; 1980 Jan; 106(1):120-4. PubMed ID: 7349950
[No Abstract] [Full Text] [Related]
9. Characterization of immunoreactive angiotensin in canine cerebrospinal fluid as Des-Asp1-angiotensin II.
Hutchinsón JS; Csicsmann J; Korner PI; Johnston CI
Clin Sci Mol Med; 1978 Feb; 54(2):147-51. PubMed ID: 620503
[TBL] [Abstract][Full Text] [Related]
10. [Des-Asp1] angiotensin II: mediator of the renin-angiotensin system?
Freeman RH; Davis JO; Lohmeier TE; Spielman WS
Fed Proc; 1977 Apr; 36(5):1766-70. PubMed ID: 321257
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic factors involved in renovascular hypertension. State of the art.
Bumpus FM; Khosla MC
Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
13. Pressor and stereoidogenic actions of [des-Asp1]angiotensin I dependency on conversion to angiotensin III.
Vaughan ED; Peach MJ; Ackerly JA; Tsai BS; Larner A
Circ Res; 1977 May; 40(5 Suppl 1):I94-7. PubMed ID: 858177
[TBL] [Abstract][Full Text] [Related]
14. Formation of DES-ASP1-angiotensin II is not an obligatory step in the steroidogenic action of angiotensin II in the canine adrenal.
Douglas J; Bartley P; Kondo T; Catt K
Endocrinology; 1978 Jun; 102(6):1921-4. PubMed ID: 744059
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and biological activities of angiotensin II and des-Asp1-angiotensin II in isolated adrenal glomerulosa cells.
Aguilera G; Capponi A; Baukal A; Fujita K; Hauger R; Catt KJ
Endocrinology; 1979 May; 104(5):1279-85. PubMed ID: 436776
[No Abstract] [Full Text] [Related]
16. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.
Santos RA; Campagnole-Santos MJ; Baracho NC; Fontes MA; Silva LC; Neves LA; Oliveira DR; Caligiorne SM; Rodrigues AR; Gropen Júnior C
Brain Res Bull; 1994; 35(4):293-8. PubMed ID: 7850477
[TBL] [Abstract][Full Text] [Related]
17. Specific receptors for des-Asp1-angiotensin II (("angiotensin III") in rat adrenals.
Devynck MA; Pernollet MG; Matthews PG; Khosla MC; Bumpus FM; Meyer P
Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4029-32. PubMed ID: 198814
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog.
Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W
Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
Bravo EL; Khosla MC; Bumpus FM
Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
[TBL] [Abstract][Full Text] [Related]
20. Vascular and adrenocortical responses to a specific antagonist of angiotensin II.
Bravo EL; Khosla MC; Bumpus FM
Am J Physiol; 1975 Jan; 228(1):110-4. PubMed ID: 1147000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
